Status:
UNKNOWN
Efficacy of rTMS on Pain Following Stroke.
Lead Sponsor:
University Hospital of Ferrara
Conditions:
Stroke
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Pain is a common symptom experienced by people following stroke and can significantly interfere with participation in the activities of daily living and adversely affect health-related quality of life...
Eligibility Criteria
Inclusion
- diagnosis of first stroke verified by brain imaging \< 6 months
- pain defined as a constant or intermittent sensory symptom with unpleasant feelings or pain and a minimum score of 3 points on the Numeric Rating Scale (NRS) for pain perception
Exclusion
- medical conditions likely to interfere with the ability to safely complete the study protocol
- cognitive functioning to give informed consent identified by a Mini-Mental Status Examination (MMSE) score ≥ 24/30
- intracranial metal implants
- history of seizures or epilepsy
- severe cardiopulmonary, renal, and hepatic diseases
- pregnancy
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03354052
Start Date
December 1 2017
End Date
May 1 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ferrara University Hospital
Ferrara, Italy, 44124